Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain.

Neuropharmacology

Department of CNS Research, Boehringer Ingelheim Pharma GmbH and Co KG, D-88397 Biberach, Germany.

Published: December 2005